Clinical Trials
- Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
- Disorders of Bone and Mineral Metabolism
- Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
- Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a
- Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
- Glucose Homeostasis in Pseudohypoparathyroidism
- Hypoparathyroidism in Denmark
- Physiologic Regulation of FGF-23
- QoL and Cognitive Function in Patients With Hypoparathyroidism
- Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism
- Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)
- Theophylline for Treatment of Pseudohypoparathyroidism
- Theophylline Treatment for Pseudohypoparathyroidism
- Theophylline Treatment for Pseudohypoparathyroidism – Children 2-12 Years Old
- A Study of SGN-STNV in Advanced Solid Tumors
- Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients
- Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
- French National Registry of Rare Peritoneal Surface Malignancies
- Gastrointestinal Microbiome Study of Appendiceal Cancer
- HIPEC Using High Intra-abdominal Pressure
- Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
- Injection of Bromelain and Acetylcysteine in Combination Into Recurrent Mucinous Tumour or Pseudomyxoma Peritonei
- International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
- Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei
- Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
- Peritoneal Surface Malignancies – Characterization, Models and Treatment Strategies
- Phase I Trial HIPEC With Nal-irinotecan
- Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
- Results of CRS and Debulking in PMP Patients
- Severe Neutropenia After HIPEC Using Mitomycin-C
- Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
- Thrombin Generation and Platelet Activation in CRS/HIPEC
- What Are the Experiences of Patients With Pseudomyxoma Peritonei?
- A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control
- Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
- Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension
- Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects.
- Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial
- Optic Nerve Sheath Diameters in Idiopathic Intracranial Hypertension Patients
- ShuntCheck in Pseudotumor Cerebri
- A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
- Arterial Wall Calcium Load in Pseudoxanthoma Elasticum
- Biological Collection of Kidney Cells
- Characterization of Pseudoxanthoma Elasticum
- Employment of Patients With Pseudoxanthoma Elasticum
- Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE
- Evolution of Visual Impairment During Pseudoxanthoma Elasticum
- Functional and Structural Characterization of Arteriopathy in Pseudoxanthoma Elasticum (PXE)
- Genetic Analysis of Patients With Pseudoxanthoma Elasticum
- Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)
- Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
- Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
- Oral Pyrophosphate Absorption in PXE Disease
- Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
- Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
- Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings
- PyROphosPHate Supplementation to Fight ECtopIc Calcification in PseudoXanthoma Elasticum
- What’s Happen Under the Calcification Process in Pseudoxanthoma Elasticum
- A National Registry For Pulmonary Alveolar Proteinosis
- Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
- The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar Proteinosis in Vitro
- Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
- : Vascular Function in Health and Disease
- (-)-Epicatechin and Pulmonary Arterial Hypertension
- (RIGHT HEART III Study – Right Ventricular Hemodynamic Evaluation and Response to Treatment)
- [18F]FES PET/CT in PAH
- 3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH
- 3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension
- 4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease
- 6R-BH4 Pulmonary Arterial Hypertension Study
- A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers
- A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
- A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Arterial Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.
- A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension
- A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
- A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
- A Long-term Follow-up Study of Sotatercept for PAH Treatment
- A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
- A Mobile Health Intervention in Pulmonary Arterial Hypertension
- A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
- A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
- A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets
- a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China
- A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin
- A nUtrition and Lifestyle Intervention in Patients With Pulmonary Arterial HypertensIon
- A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses
- A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
- A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
- A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
- A Phase 3 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of L606 in Subjects With PAH
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
- A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease
- A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain
- A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.
- A Registry for Patients Taking Uptravi
- A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
- A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
- A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
- A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
- A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag
- A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
- A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
- A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2)
- A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)
- A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging
- A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist
- A Study of Single Doses of MK -5475 on Pulmonary Vascular Resistance (MK-5475-002)
- A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
- A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
- A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR)
- A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality
- A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
- A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension (MK-5475-007)
- A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
- A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
- A Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
- A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)
- A Study to Evaluate GSK1325760A – a Long-Term Extension Study
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
- a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects
- A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers
- A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH
- A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)
- A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
- A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
- ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension
- Absorption, Distribution, Metabolism and Excretion of BIA 5-1058
- ACT-293987 in Pulmonary Arterial Hypertension
- Actigraphy in Pediatric Pulmonary Hypertension
- Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)
- Acute Effects of Benzbromaron on the Pulmonary Circulation
- Acute Exposure of High Altitude on Cognitive Function
- Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS)
- Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension
- Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension
- ADAMTSL4 in Idiopathic Pulmonary Hypertension and CTEPH
- ADAPT – A Patient Registry of the Real-world Use of Orenitram®
- Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
- Adult Congenital Heart Disease Registry (QuERI)
- Aerobic Exercise Training in Pulmonary Arterial Hypertension
- Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension
- Algorithms to Diagnose Pulmonary Arterial Hypertension
- ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
- An Open Label Access Study For Subjects Who Completed A1481156
- An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
- An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients
- An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
- Analysis of the Severity and Prognosis of Pulmonary Hypertension Associated With Bronchiectasis.
- Anastrozole in Patients With Pulmonary Arterial Hypertension
- Angiogenic Imaging in Pulmonary Arterial Hypertension
- Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension
- Anxiety Self-management Intervention for Pulmonary Hypertension
- Apabetalone for Pulmonary Arterial Hypertension
- Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
- ARIES – Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)
- Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
- Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH
- Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
- Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise
- Assessment of Right Ventricular Function by Cardiac MRI in Patients With Pulmonary Arterial Hypertension (IRMA)
- Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension
- Assessmet of Patients With PAH Right Ventricular Volume
- BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension
- Beraprost-314d Added-on to Tyvaso® (BEAT)
- Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
- Beta-blockers in i-PAH
- Beta-blockers in Pulmonary Arterial Hypertension
- Biomarkers in Pediatric Congenital Heart Disease and PAH
- Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib
- Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
- Biomarkers in the Evaluation of Chronic Lung Disease
- Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension
- BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension
- Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure
- Bosentan and Pulmonary Endothelial Function
- Bosentan in Children With Pulmonary Arterial Hypertension
- Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
- BPS-314d-MR-PAH-303 (BEAT OLE)
- BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
- Bronchodilator’s Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
- Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
- Cardiac Magnetic Resonance Imaging and Pulmonary Perfusion
- Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
- Carvedilol PAH A Pilot Study of Efficacy and Safety
- Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects
- Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study
- Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration
- Characterization of the Liver Parenchyma Using Parametric T1 and T2 Magnetic Resonance Relaxometry
- Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome
- Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
- Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)
- Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension
- Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
- Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
- Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
- Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
- Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
- Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
- Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH
- Coenzyme Q-10 and Pulmonary Arterial Hypertension
- Combination Therapy in Pulmonary Arterial Hypertension
- Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan
- Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication
- Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
- Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)
- Comparison of Different Cardiac Output Measurement Methods in Patients Undergoing Right Heart Catheterization
- Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- COMPERA / COMPERA-KIDS
- COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina
- Consistency of Electrical Cardiometry and Pulmonary Artery Catheter
- Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
- Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension
- Correlation of Right Atrial Strain With Pulmonary Hypertension, Right Ventricular Function And Outcome In Pediatric Patients
- Crossover Study From Macitentan or Bosentan Over to Ambrisentan
- CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
- Dapagliflozin in Pulmonary Arterial Hypertension
- Data Analysis for Drug Repurposing for Effective Alzheimer’s Medicines (DREAM)- PDE5 Inhibitors vs Endothelin Receptor Antagonist
- DataBase of pulmoNary hyPertesion in PoLish Population – BNP-PL
- DelIVery for Pulmonary Arterial Hypertension (PAH)
- Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
- DNA Methylation Dynamics Underlying Arterial Remodeling in PAH Patients: CLEOPAHTRA Clinical Trial
- Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension
- Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
- Drug Interaction Between Ritonavir And Sitaxsentan
- Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
- Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH
- Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
- Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
- Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System
- Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058
- Effect of BIA 5 1058 on Cardiac Repolarization
- Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
- Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil
- Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics
- Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil
- Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension
- Effect of CS1 in Subjects With Pulmonary Arterial Hypertension
- Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
- Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary Hypertension
- Effect of Food on BIA 5-1058
- Effect of Food on the Pharmacokinetics of Oral Treprostinil
- Effect of Home Rehabilitation on State of Patients With PAH, HFREF and IHD
- Effect of Inhaled Albuterol in Pulmonary Hypertension
- Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
- Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
- Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension
- Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH
- Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan
- Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.
- Effects of DHEA in Pulmonary Hypertension
- Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension.
- Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease
- Effects of Oral Sildenafil on Mortality in Adults With PAH
- Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension
- Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension
- Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH
- Effects of RT234 on Exercise Parameters Accessed by CPET in Subjects With PAH
- Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
- Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension
- Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
- Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH
- Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
- Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension
- Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension
- Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension
- Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
- Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children
- Efficacy of Ventavis Used in Real-life Setting.
- Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
- Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
- Eisenmenger Quality Enhancement Research Initiative
- Empagliflozin in Pulmonary Arterial Hypertension
- Endothelial Cell Dysfunction in Pulmonary Hypertension
- Endothelial Function in Patients With Pulmonary Arterial Hypertension
- Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension
- Epoprostenol for Injection (EFI/ACT-385781A) – Pulmonary Arterial Hypertension
- Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
- Epoprostenol for Injection in Pulmonary Arterial Hypertension
- Epoprostenol for Injection in Pulmonary Arterial Hypertension – Extension of AC-066A401
- Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography
- Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
- Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
- Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
- Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)
- Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography Imaging
- Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension
- Evaluation of the Influence of Face Masks on the Outcome of the 6MWD and Quality of Life in Patients With Pulmonary Hypertension
- Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.
- Evaluation of the Strength of Handgrip in Patients With Pulmonary Artery Hypertension
- Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate
- Exercise Capacity Respiratory Muscle Strength Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension
- Exercise Training in Patients With Pulmonary Arterial Hypertension
- Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
- EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
- Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
- Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
- Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
- Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
- Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
- Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
- Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
- FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan
- Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
- FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
- Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial
- FREEDOM – M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
- FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
- FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
- FUTURE 3 Study Extension
- GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
- Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
- Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension
- Genetics of Pulmonary Hypertension
- Giessen Pulmonary Hypertension Registry and Biobank
- Glucocorticoids and Pulmonary Hypertension
- Goal Oriented Strategy to Preserve Ejection Fraction Trial
- Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
- Hemodynamic Response After Six Months of Sildenafil
- Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism
- Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension
- HRV as a Marker of Treatment Response in PAH Arterial Hypertension
- Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)
- HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION
- Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
- Iloprost Power 15 in Pulmonary Arterial Hypertension
- Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
- Imaging Control Study, 3D Echo, MR and RHC.
- Imatinib (QTI571) in Pulmonary Arterial Hypertension
- Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension
- Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
- Impact of Polymorphism on Pulmonary Pressure in Subjects With Pulmonary Hypertension of Different Cause
- Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.
- Implantable System for Remodulin Post-Approval Study
- Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL)
- Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
- Inhaled Treprostinil for PAH: Open-label Extension
- Inspiratory Muscle Training in Pulmonary Arterial Hypertension
- Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension
- Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
- Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
- Iron Deficiency In Pulmonary Hypertension
- Iron Status and Hypoxic Pulmonary Vascular Responses
- IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients
- Ketones for Pulmonary Hypertension – Effects on Hemodynamics
- LenusPro Pump in PAH Treated With Treprostinil
- LenusPro Safety (LPS) Study in Patients With PH
- Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
- Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
- Long Term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
- Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
- Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients
- Long-term Outcomes of Pregnant Women With PAH
- Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
- Long-Term, Open Label Extension Study of PB1046 in PAH Subjects Following Completion of Study PB1046-PT-CL-0004
- Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension
- Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients
- Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)
- Medication Reconciliation in Pulmonary Hypertension
- Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
- Mexican Registry of Pulmonary Hypertension
- Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study
- MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
- Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
- Multi-marker Approach for Risk Assessment in PAH
- National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension
- National Registry and Cohort Study of Pulmonary Vascular Disease
- Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
- Neuromuscular Electrical Stimulation in Pulmonary Arterial Hypertension
- Nitric Oxide, GeNO Nitrosyl Delivery System
- Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
- Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
- Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
- Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
- Non-invasive Pulmonary Artery Prediction
- Non-invasive Pulmonary Artery Prediction (ADOPTS)
- Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension
- Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients
- Obstructive Sleep Apnea in Pulmonary Arterial Hypertension (OSA in PAH)
- Olaparib for PAH: a Multicenter Clinical Trial
- Olaparib for PAH: a Pilot Study
- Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
- Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension
- Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
- Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
- Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
- Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
- OPsumit USers Registry
- Oral CXA-10 in Pulmonary Arterial Hypertension
- Oral Iron Supplementation in Pulmonary Hypertension
- Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
- Oxygen Treatment and Pulmonary Arterial Hypertension
- PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
- Patient Global Impression Questions for Activity-induced Symptoms in Patients With PAH
- Patient Reported Outcomes in Pulmonary Arterial Hypertension
- Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- PET Image in PAH Patients
- PET/MRI in PAH Patients
- Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
- Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine
- Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH
- Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
- Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension
- Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
- Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC PB1046 in Subjects With Symptomatic PAH
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
- Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
- PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension
- Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
- Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
- Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension
- Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide
- Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
- Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
- Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
- Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension
- Positioning Imatinib for Pulmonary Arterial Hypertension
- Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension
- Prevalence of Musculoskeletal Pain and Its Impact on Quality of Life and Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension
- Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients
- Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
- Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension
- PRIMEx – A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
- Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)
- Prognostic Value of the Evaluation of Right Ventricular Function by Portable Ultrasound in Patients With Pulmonary Hypertension.
- Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
- Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking Anorectics
- Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
- Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
- Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
- Pulmonary Hypertension and Anastrozole Trial
- Pulmonary Hypertension and Imatinib
- Pulmonary Hypertension Association Registry
- Pulmonary Hypertension Biorepository and Registry
- Pulmonary Hypertension in Interstitial Lung Disease
- Pulmonary Hypertension Modality of Death and Validation of REVEAL Risk Score
- Pulmonary Hypertension Registry Switzerland
- Pulmonary Vascular Disease Phenomics Program PVDOMICS
- Quality of Life Assessed With the PAH SYMPACT Questionnaire
- Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)
- Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
- Ranolazine and Pulmonary Hypertension
- Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
- Registry for Pulmonary Hypertension in China
- REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)
- Rehabilitation for Patients With Pulmonary Arterial Hypertension
- Relation Between Mean Pulmonary Artery Pressure and Pulmonary Acceleration Time and Comparison With Previous Formulae
- Remodulin® to Oral Treprostinil Transition
- Remote Exercise Program Delivery Using a Mobile Application for Pulmonary Arterial Hypertension
- REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension
- Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
- Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension
- Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
- Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects
- Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
- Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
- Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
- Retrospective Data Analysis of Data From the Zurich PH Registry
- Revatio Portal-Pulmonary Arterial Hypertension Trial
- Revavtio Special Investigation for Long-term Use in Pediatric Patients
- REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management
- Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
- Right Atrial Fibrosis in Pulmonary Hypertension
- Right Ventricular Metabolism in Pulmonary Arterial Hypertension
- Right Ventricular Pacing in Pulmonary Arterial Hypertension
- Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
- Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
- Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)
- Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension
- RUS-registry of PH
- RV Systolic and Diastolic Function and Contractile Reserve Under Acute Exercise and in Response to Chronic Exercise-based Rehabilitation
- RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists
- Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
- Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
- Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
- Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
- Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
- Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension
- Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
- Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
- Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
- Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
- Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension
- Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
- Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
- Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
- Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
- Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
- Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension
- Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
- Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
- Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
- Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution
- Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
- Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
- Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058
- Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
- Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers
- Screening of Pulmonary Hypertension in Methamphetamine Abusers
- Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
- Selonsertib in Adults With Pulmonary Arterial Hypertension
- Sildenafil and Pulmonary Artery Pressure
- Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD)
- Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil
- Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
- Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585
- Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
- Single-Dose, Open Label Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
- Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH
- Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment
- Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- Spironolactone for Pulmonary Arterial Hypertension
- StratosPHere (Non-interventional Study)
- Stress Echo 2020 – The International Stress Echo Study
- Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil
- Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)
- Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
- Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension
- Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)
- Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
- Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
- Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
- Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
- Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
- Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric
- Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
- Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertension
- Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients
- Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death
- Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients
- Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function
- Study on the Use of Inhaled NO (iNO)
- Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
- Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety
- Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
- Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
- Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
- Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension
- Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)
- Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
- Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
- Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension
- Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- Subcutaneous Elafin in Healthy Subjects
- Surgical Valvuloplasty for Congenital Mitral Insufficiency
- Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery
- Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
- Telerehabilitation Program Via Videoconference PAH – Randomized Clinical Trial
- Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension
- Tezosentan in Patients With Pulmonary Arterial Hypertension
- Tezosentan in Pulmonary Arterial Hypertension
- The “Power 15 Study”: Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting
- The “VISION” Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension
- The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
- The Early Recognition of Pulmonary Arterial Hypertension
- The Effect of Adding Exercise Training to Optimal Therapy in PAH
- The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia
- The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
- The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension
- The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
- The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH
- The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
- The Expression and Significance of MiRNA
- The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
- The PAH Disability and Bothersomeness Questionnaire
- The PAH Platform for Deep Phenotyping in Korean Subjects
- The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
- The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension
- The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD
- The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects
- Therapy of Pulmonary Arterial Hypertension (PAH) – Treatment With Sildenafil in Eisenmenger Patients
- To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
- To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers
- To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks
- Training With Whole Body Vibration Device in Patients With PAH
- Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
- Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
- TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- TReatment Of Pulmonary HYpertension 1 Study
- TReatment Of Pulmonary HYpertension 1-US Study
- Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
- Treprostinil Combined With Tadalafil for Pulmonary Hypertension
- Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
- Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
- Trimetazidine in Pulmonary Artery Hypertension
- TROPHY PAH Pivotal Study – TReatment of Pulmonary HYpertension for PAH Pivotal Study
- TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)
- Tyvaso Dosing and Titration Evaluation: TyTRATE Registry
- Upfront Combination Pulmonary Arterial Hypertension Therapy
- Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension
- Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test
- Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost
- Vascular Subphenotypes of Lung Disease in HIV & COPD
- Ventavis® Registry Protocol
- Ventricular Reversed Remodeling After LTX in PAH Patients
- Xenon MRI Pulm Hypertension
- A Review of Surgical Management of Congenital Pulmonary Airway Malformations (CPAM): A Decade of Experience
- Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs
- Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction
- Contrast Echocardiography in Patients With Pulmonary Arteriovenous Malformations (PAVMs)
- Locked-in Syndrome Caused by Pulmonary Arteriovenous Malformation: A Case Report
- Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)
- Pulmonary Arteriovenous Malformations (PAVMs) in Hereditary Haemorrhagic Telangiectasia (HHT)
- Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy
- A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed iNO in Subjects With Pulmonary Fibrosis
- A Non-pharmacological Cough Control Therapy
- A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis
- A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
- A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device
- A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
- A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
- A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
- A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- A Study to Evaluate the Safety and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects
- Accuracy of Spircare Device as Compared to the Conventional Plethysmograph
- Advancing Prevention of Pulmonary Fibrosis
- An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
- Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
- Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
- Assessment of Pulmonary Specialty Physicians’ Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
- Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation
- BIO 300 Oral Suspension in Discharged COVID-19 Patients
- Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
- Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
- Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease
- Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis
- Computerized Lung Sound Analysis
- COVID-19 Pathophysiology of Long Term Implications
- Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
- Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)
- Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study
- Diagnostic Value of KL-6 in ILD
- Dyspnea and Idiopathic Pulmonary Fibrosis
- Dyspnea in Patients With Pulmonary Fibrosis
- Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis
- Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis
- Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab
- European Management Platform for Childhood Interstitial Lung Diseases – chILD-EU Register and Biobank
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
- Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD
- Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis
- Explanted Lung Tissues With Pulmonary Fibrosis
- Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology
- FAPI PET for Lung Fibrosis
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
- Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome
- Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
- Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT
- Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
- Idiopathic Pulmonary Fibrosis: a Case-control Study
- Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
- Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
- Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
- Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
- Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
- Linkage Study in Familial Pulmonary Fibrosis
- Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study
- Lung Disease Associated With Rheumatoid Arthritis
- LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION
- Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
- Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
- Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan
- Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
- Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis
- Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies
- Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment
- Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis
- Post Acute Sequelae of COVID-19
- Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
- Pulmonary Fibrosis and Telomerase Mutation Study
- Pulmonary Fibrosis During Severe COVID-19 Pneumonia
- Pulmonary Fibrosis Foundation Community Registry
- Pulmonary Fibrosis Lung Sounds Study
- Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.
- RENOVATE Fibrosis: Pilot Study Comparing HFNC Versus NIPPV in Acute Respiratory Failure in Patients With Pulmonary Fibrosis
- Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression
- Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
- Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
- Safety and Effectiveness of EV-Pure + WJ-Pure Treatment on Pulmonary Fibrosis Secondary to Covid-19
- Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients
- Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
- Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis
- Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
- Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)
- Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
- Safety of Nintedanib in Real World in China
- Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
- Segmental Bronchoalveolar Lavage
- Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
- Spanish Version of the KBILD Questionnaire
- Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
- Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis
- Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
- Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
- Supplemental Oxygen in Pulmonary Fibrosis
- Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
- Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
- The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
- The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19
- The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID
- The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis
- Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients
- Using Health-related Quality of Life (HRQL) in Routine Clinical Care
- Vaccination of Ex-acute COVID Patied-19 Patients With Fibrosing Lung Syndrome at Discharge
- Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease
- COMPASSION – COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
- Multicenter Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent
- Pulmonary Arteriopathy-Diagnostics and Therapy
- Pulmonary Artery Repair With Covered Stents
- Pulmonic Valve REplacement Multi-discIpline EMEA Registry
- Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
- Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
- Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis
- PIC and Its Role in Progression of Pathological Myopia
- A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment
- A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
- A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
- Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment
- Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
- Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia
- Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA
- Sirolimus Treatment for Refractory PRCA
- Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure
- Tacrolimus Treatment for Refractory Autoimmune Cytopenia
- Tacrolimus Treatment for Refractory PRCA
- The Use of Trifluoperazine in Transfusion Dependent DBA